ConductScience.org, home

Paper38010703

Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.

Böttger F and 12 others. Mol Oncol, 2024. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer. Papers, record 38010703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38010703

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Identification of protein biomarkers for prediction of response to platinum-based treatment regimens in patients with non-small cell lung cancer.
PubMed
Journal
Mol Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
1.08, provisional
iCite
Revised in PubMed
2026-08-03
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Böttger FFranziskahttps://orcid.org/0000-0001-8364-4087
2Radonic TTeodora
3Bahce IIdris
4Monkhorst KKim
5Piersma SRSander R
6Pham TVThang V
7Dingemans ACAnne-Marie C
8Hillen LMLisa Mhttps://orcid.org/0000-0002-8808-4952
9Santarpia MMariacarmela
10Giovannetti EElisa
11Smit EFEgbert F
12Burgers SASjaak A
13Jimenez CRConnie Rhttps://orcid.org/0000-0002-3103-4508

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Non-Small-Cell LungMajor topic
Lung NeoplasmsMajor topic
Biomarkers, TumorMajor topic
Humans
Female
Male
Aged
Middle Aged
Proteomics
HMGB1 Protein
Platinum
Cohort Studies

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
24444Associazione Italiana per la Ricerca sul Cancro (AIRC)PubMed
2014-6816KWF KankerbestrijdingPubMed
91116017The Netherlands Organization for Scientific ResearchPubMed
VUmc-Cancer Center AmsterdamPubMed

Source PubMed

Download CSV of grants

References61

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125152373SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.Cell Signal2014https://conductscience.org/library/papers/25152373PubMed
230208165DNA repair pathways and cisplatin resistance: an intimate relationship.Clinics (Sao Paulo)2018https://conductscience.org/library/papers/30208165PubMed
336776323Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone.Front Oncol2023https://conductscience.org/library/papers/36776323PubMed
433538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed
530710758Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.J Proteomics2019https://conductscience.org/library/papers/30710758PubMed
626040768Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.Tumour Biol2015https://conductscience.org/library/papers/26040768PubMed
729083409Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.Nat Genet2017https://conductscience.org/library/papers/29083409PubMed
827364315The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.J Thorac Oncol2016https://conductscience.org/library/papers/27364315PubMed
924996221HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.Mol Cancer2014https://conductscience.org/library/papers/24996221PubMed
1027893326Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).J Clin Oncol2017https://conductscience.org/library/papers/27893326PubMed
1129566065Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.PLoS One2018https://conductscience.org/library/papers/29566065PubMed
1221332310Impact of ABCG2 polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients.Pharmacogenomics2011https://conductscience.org/library/papers/21332310PubMed
1320007255On the beta-binomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics.Bioinformatics2010https://conductscience.org/library/papers/20007255PubMed
1418089836A new mechanism of 6-((2-(dimethylamino)ethyl)amino)-3-hydroxy-7H-indeno(2,1-c)quinolin-7-one dihydrochloride (TAS-103) action discovered by target screening with drug-immobilized affinity beads.Mol Pharmacol2008https://conductscience.org/library/papers/18089836PubMed
1530171261mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer.Oncogene2019https://conductscience.org/library/papers/30171261PubMed
1631524278FKBP3 mediates oxaliplatin resistance in colorectal cancer cells by regulating HDAC2 expression.Oncol Rep2019https://conductscience.org/library/papers/31524278PubMed
1734645978A highly annotated database of genes associated with platinum resistance in cancer.Oncogene2021https://conductscience.org/library/papers/34645978PubMed
1820066897Combined effect of rapamycin and cisplatin on survival of Hep-2 cells in vitro.Oncol Res2009https://conductscience.org/library/papers/20066897PubMed
1929768183NDRG1 disruption alleviates cisplatin/sodium glycididazole-induced DNA damage response and apoptosis in ERCC1-defective lung cancer cells.Int J Biochem Cell Biol2018https://conductscience.org/library/papers/29768183PubMed
2036108662
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial.
Lancet Oncol2022https://conductscience.org/library/papers/36108662PubMed

See all 61 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41293424Clinical application and drug resistance mechanism of gemcitabine.Front Cell Dev Biol2025https://conductscience.org/library/papers/41293424PubMed
40804938HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype.Diagnostics (Basel)2025https://conductscience.org/library/papers/40804938PubMed
40702552Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40702552PubMed
40515965Canthaxanthin downregulates EGFR in NSCLC: network pharmacology, molecular docking, dynamics simulations, ADMET, and in-vitro analysis.Mol Divers2026https://conductscience.org/library/papers/40515965PubMed
39092034Combination of anlotinib and second-line chemotherapy as surrogate to reduce immunosuppression in patients with advanced non-small cell lung cancer.Pak J Med Sci2024https://conductscience.org/library/papers/39092034PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38010703

GET https://conductscience.org/api/papers/v1/38010703/references?page=2